INGN NASDAQ
Credit Risk of going bust: lower than 69% of companies Debt: 7.8% of company value Bonds: none of note held by US funds details ▾
If the stock fell to about $0.06 (down 99.2%), Inogen, Inc. would be worth roughly what it owes.
Total debt $15.8M against a stock market value of $187.9M.
Distance to default 7.44 (Merton model): prices to 2026-10-26, balance sheet 2026-06-30, debt counted $7.9M (short-term plus half of long-term), stock volatility 44.2%; Altman Z 1.56. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.
Beverly, MA 01915
US
Inogen, Inc. operates as a medical technology enterprise dedicated to designing, fabricating, and distributing oxygen concentration equipment. These cutting-edge devices are engineered to provide continuous oxygen support for patients managing persistent respiratory conditions. The company's diverse product range features the popular portable Inogen One, which efficiently draws oxygen from the surrounding atmosphere to offer an independent supply, alongside stationary Inogen At Home concentrators, Tidal Assist Ventilators, and various associated accessories. Inogen serves a broad clientele, including individual patients, medical professionals, and insurance providers, both domestically in the United States and globally. Furthermore, the company facilitates direct equipment rentals to patients. Founded in 2001, Inogen, Inc. is headquartered in Goleta, California.
Recent Insider Trades
| Name | Type | Shares | Price | Date |
|---|---|---|---|---|
| Wright Mary E | A-Award | 1,500 | $5.33 | 2026-09-01 |
| Smith Kevin P. | A-Award | 1,500 | $5.33 | 2026-09-01 |
| Smith Kevin P. | M-Exempt | 18,136 | — | 2026-09-01 |
| Smith Kevin P. | F-InKind | 8,671 | $5.33 | 2026-09-01 |
| Smith Kevin P. | M-Exempt | 18,136 | — | 2026-09-01 |